Table 1 The basic information and clinical features of the pregnant women.

From: Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads

  

Groups

t

p value

TDF treatment (n = 59) Mean ± SD

%

Control (n = 52) Mean ± SD

%

Pregnant women

Age (y)

28.31 ± 3.56

 

28.06 ± 3.42

 

0.379

0.705

Pregnancy number

1.28 ± 0.451

 

1.25 ± 0.437

 

0.305

0.761

Basal ALT level (U/L)

54.62 ± 105.7

 

57.5 ± 103.3

 

−0.145

0.88

HBV genotype

     

0.809

  B2

4

6.9

3

5.8

  

  C2

54

93.1

49

94.2

  

Family status

Domicile

     

0.262

  Rural

33

56.9

35

67.3

  

  City

25

43.1

17

32.7

  

Residency

     

0.994

  Temporary

19

32.8

17

32.7

  

  Resident

39

67.2

35

67.3

  

Education

     

0.823

  Below college

39

67.2

36

69.2

  

  College and above

19

32.8

16

30.8

  

Family incomes (year)

     

0.976

  <40,200 RMB

18

31.0

16

30.8

  

  >40,200 RMB

40

69.0

36

69.2

  
Back to article page